Pricing Log in Create free account
Saturday 17 October 2026 Export IDXX’s income statement to Excel — free account

IDEXX Laboratories, Inc.

IDXX Healthcare Diagnostics & Research

IDEXX Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 10.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.66%, EPS grew 17.2%, free cash flow grew 111.4% and total debt fell 14.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years, operating cash flow growth for three.

560.36 13.18 +2.41%
Market cap
$43.1B
P/E
39.1×
Fwd P/E
38.3×
Dividend yield
—
F-score
8/9
Altman Z
24.09
Beneish M
−2.50
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

IDEXX Laboratories, Inc. (IDXX) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, IDEXX Laboratories, Inc. (IDXX) trades at a EV/EBITDA of 27.6×. Over the past ten years it has ranged from 16.9× (January 2016) to 63.2× (August 2021); the current reading is higher than 21% of that period. That is above the Diagnostics & Research industry median of 24.3× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 36.3× 32.78%
FY2024 27.4× (27.50%)
FY2023 37.7× 10.20%
FY2022 34.2× (37.51%)
FY2021 54.8× 0.31%
FY2020 54.6× 49.61%
FY2019 36.5× 26.09%
FY2018 29.0× 2.73%
FY2017 28.2× 12.52%
FY2016 25.1× 32.37%

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 25.9× (10.41%)
Mar 2026 28.9× (20.33%)
Dec 2025 36.3× 2.04%
Sep 2025 35.6× 14.02%
42 more quarters

Against its own ten years

Low 16.9× High 63.2×
Ten-year median 33.6×
Current reading's percentile 21

EV/EBITDA against peers

Company EV/EBITDA
NTRA Natera, Inc. compare n/m
DGX Quest Diagnostics Incorporated compare 14.1×
LH Labcorp Holdings Inc. compare 14.5×
IQV IQVIA Holdings Inc. compare 17.1×
A Agilent Technologies, Inc. compare 26.5×
MTD Mettler-Toledo International, Inc. compare 26.6×
IDXX IDEXX Laboratories, Inc. 27.6×
ILMN Illumina, Inc. compare 35.0×
WAT Waters Corporation compare 50.1×
Diagnostics & Research industry median 24.3×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on IDXX